Skip to main content

Table 3 Assessment of Knowledge regarding Mucormycosis and COVID-19 manifestation (n = 73 participants)

From: Effect of nurse-led intervention on knowledge and preventive behavior of diabetic pregnant women regarding COVID-19 associated mucromycosis infection in mid-delta region of Egypt

Variables

Pre Intervention

Three Months Post Intervention

p-value a

No

%

No

%

Knowledge regarding Mucormycosis

The definition of Mucormycosis

- Correct

- Incorrect/I don’t Know

15

58

20.5

79.5

51

22

69.9

30.1

< 0.001

The causes of Mucormycosis

- Correct

- Incorrect

12

61

16.4

83.6

43

30

58.9

41.1

< 0.001

The symptoms of Mucormycosis

- Correct

- Incorrect

14

59

19.2

80.8

47

26

64.4

35.6

< 0.001

The risk factors of Mucormycosis

- Correct

- Incorrect

10

63

13.7

86.3

58

15

79.5

20.5

< 0.001

The complications of Mucormycosis

- Correct

- Incorrect

7

66

9.6

90.4

39

34

53.4

46.6

< 0.001

The management of Mucormycosis

- Correct

- Incorrect

13

60

17.8

82.2

51

22

69.9

30.1

< 0.001

Knowledge about maternal signs and symptoms of COVID-19 infection

Cough

- Correct

- Incorrect

66

7

90.4

9.6

73

0

100

0

0.016

Shortness of breath

- Correct

- Incorrect

53

20

72.6

27.4

63

10

86.3

13.7

0.002

An increase in temperature

- Correct

73

100

73

100

-

Muscle pain

- Correct

- Incorrect

61

12

83.6

16.4

63

10

86.3

13.7

0.774

Sore throat

- Correct

- Incorrect

63

10

86.3

13.7

66

7

90.4

9.6

0.508

New loss of taste or smell.

- Correct

- Incorrect

65

8

89.0

11.0

71

2

97.3

2.7

0.070

Total knowledge scores

Mean ± SD

Range

6.19 ± 1.66

2–10

9.56 ± 1.75

4–12

p-value b

< 0.001

  1. The total knowledge score is calculated by summation of knowledge answers; where incorrect answer/I don’t know = 0, and correct answer = 1, a McNemar test, b Paired t-test.